Hexaminolevulinate (HAL) photodynamic therapy

hexaminolevulinate · Photocure ASA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hexaminolevulinate (HAL) photodynamic therapy, covering 2013-04-15 to 2013-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1 [Phase 2]